Different attitudes of oncology clinicians toward truth telling of different stages of cancer.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Yu JiangYu-quan Wei

Abstract

To investigate different attitudes of oncology clinicians toward whether and how to disclose diagnosis to patients with different stages of cancer. A questionnaire investigating physician's demographic information and attitude toward truth telling was delivered to 256 Chinese oncology clinicians. Two hundred thirty-two (90.6%) physicians completed the questionnaire. Of these oncology clinicians, 87.5% reported that a patient with early-stage cancer should be informed of the diagnosis, while only 40.5% believed that a patient with terminal illness should know the truth (P<0.001). Physicians who preferred to tell the truth reported that patients with early or terminal stage of cancer should be informed by the doctor-in-charge (81.3 vs 77.7%, respectively; P>0.05), immediately after the diagnosis (83.7 vs 87.2%, respectively), and in a quiet and undisturbed room (63.5 vs 68.1%, respectively; P>0.05). In stepwise multiple logistic regression analyses, no demographic information showed association with truth telling of early-stage cancer. Women doctors [odds ratio (OR), 2.25; 95% CI, 1.31 to 3.89; P=0.004] were more likely than men to want the patient to be informed of the terminal illness. Physicians with cancer relatives (OR, 0.55...Continue Reading

References

Mar 2, 1979·JAMA : the Journal of the American Medical Association·D H NovackJ M Bennett
Feb 20, 1993·Lancet·O O ThomsenP A Singer
Sep 21, 1996·BMJ : British Medical Journal·C MeredithL Fallowfield
Oct 23, 1998·Social Science & Medicine·G N Hamadeh, S M Adib
May 26, 1999·Australian and New Zealand Journal of Medicine·X HuangD Goldstein
Sep 22, 1999·Journal of General Internal Medicine·M D FeldmanS R Cummings
Oct 29, 1999·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·F L PimentelJ P Maia-Gonçalves
Jan 29, 2000·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·L GrassiG Cartei
Feb 24, 2001·Palliative Medicine·J Ferraz Gonçalves, S Castro
Jun 26, 2003·Palliative Medicine·C Y TseS Y Fok
Jan 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Young Ho YunChang Hoon You
Jan 30, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Figen Culha AtesciNursel Karagoz
Apr 13, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Kyriaki MystakidouLambros Vlahos
Apr 17, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Mustafa OzdoganYeliz Sualp
May 1, 2004·Atencion primaria·V Rubio ArribasV Tapiz Ibáñez
May 26, 2004·Journal of Pain and Symptom Management·Xin Shelley WangCharles S Cleeland
Jul 17, 2004·Journal of Psychosomatic Research·Shing-Yaw WangHuei-Lin Huang
Sep 17, 2004·The Journal of Medicine and Philosophy·Ruiping Fan, Benfu Li

❮ Previous
Next ❯

Citations

Jan 29, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·R BracciA Piga
Jul 16, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Dian-can WangFan Chen
Oct 20, 2010·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Zi-ming LiuYu Jiang
Jun 1, 2011·Palliative & Supportive Care·Maria FriedrichsenAnna Milberg
Jan 16, 2009·Death Studies·Chiung-yin HsuSusan Lee
Apr 10, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Bo XieMing Zhang
Jun 17, 2014·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Wenwen SunMinmin Li
Aug 31, 2013·Oncology Nursing Forum·Rana F ObeidatRobin M Lally
Oct 27, 2015·Cancer Nursing·Hai-Chiao ChenShu-Hui Lee
Nov 11, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Yi Hu Ni, Terje Alræk
Mar 4, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Efharis PanagopoulouAlexis Benos
May 29, 2015·The American Journal of Hospice & Palliative Care·Shanshan WeiEduardo Bruera
Jun 24, 2020·Asia-Pacific Journal of Clinical Oncology·Ssu Wynn MonChetna Malhotra
Apr 9, 2021·Frontiers in Psychiatry·Ayelet Brand-GothelfOrit Karnieli-Miller

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Walter F BaileLorenzo Cohen
Journal of Psychosomatic Research
Shing-Yaw WangHuei-Lin Huang
Annals of the New York Academy of Sciences
S Li, J L Chou
© 2022 Meta ULC. All rights reserved